The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic

BACKGROUND: SARS-CoV-2 viral infection causes COVID-19 that can result in severe acute respiratory distress syndrome (ARDS), which can cause significant mortality, leading to concern that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks for both infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, David, Amor, Sandra, Kang, Angray S., Schmierer, Klaus, Giovannoni, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214323/
https://www.ncbi.nlm.nih.gov/pubmed/32464584
http://dx.doi.org/10.1016/j.msard.2020.102174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214323/
https://www.ncbi.nlm.nih.gov/pubmed/32464584
http://dx.doi.org/10.1016/j.msard.2020.102174

Ejemplares similares